Active substance |
Nirogacestat |
| Holder | Bionical Emas T/A Bionical Limited (on behalf of Springworks Therapeutics) |
| Status | Running |
| Indication | Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF) |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 15/03/2024 |